FDA Approves Rituximab Biosimilar; Plus New Safety Data for Filgotinib in RA Patients
Can IL-6 Predict Sarilumab Response?
Bimekizumab Promising for PsA
Long-Term Data Show Baricitinib Is Safe & Effective for RA
Upadacitinib Monotherapy Proves Promising; Plus FDA Approves Tocilizumab Autoinjector
FDA Update: Topical Plaque Psoriasis Treatment Approved; Dupilumab Will Receive FDA Priority Review
Rituximab Receives Label Update for ANCA-Associated Vasculitis
FDA Approves Subcutaneous Tocilizumab for Ages 2–17
Plaque Psoriasis Treatments: BMS-986165 Promising & Adalimumab Biosimilar Demonstrates Equivalence
- 1
- 2
- 3
- …
- 15
- Next Page »